# Processa Pharmaceuticals, Inc.: Form 8-K, filed Aug 4, 2026

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 17:25 ET
- Period: 2026-07-30
- Accession: 0001493152-26-036032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-036032. Last ingested by Listed: Nov 5, 2026, 12:19 ET. No prices; not investment advice.